Cas:51390-23-9 3-(1H-Imidazol-1-yl)-1-propanol manufacturer & supplier

We serve Chemical Name:3-(1H-Imidazol-1-yl)-1-propanol CAS:51390-23-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(1H-Imidazol-1-yl)-1-propanol

Chemical Name:3-(1H-Imidazol-1-yl)-1-propanol
CAS.NO:51390-23-9
Synonyms:3-imidazol-1-yl-propanol;3-N-(imidazoyl)propan-1-ol;1-(3-Hydroxypropyl)-1H-imidazole;3-(1H-Imidazol-1-yl)-1-propanol;3-hydroxypropylimidazole;3-(1H-imidazol-1-yl)propan-1-ol;3-imidazol-1-yl-propan-1-ol;1-(3-hydroxypropyl)imidazole;3-(1-imidazolyl)propanol;1H-Imidazole-1-propanol
Molecular Formula:C6H10N2O
Molecular Weight:126.156
HS Code:2933290090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:326.3±25.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.540
PSA:38.05000
Exact Mass:126.079315
LogP:-0.55

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-imidazol-1-yl-propanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Imidazole-1-propanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-hydroxypropyl)imidazole Use and application,3-imidazol-1-yl-propan-1-ol technical grade,usp/ep/jp grade.


Related News: At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 3-(1H-Imidazol-1-yl)-1-propanol manufacturer In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 3-(1H-Imidazol-1-yl)-1-propanol supplier In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 3-(1H-Imidazol-1-yl)-1-propanol vendor The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 3-(1H-Imidazol-1-yl)-1-propanol factory Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings.